PSTX
Poseida Therapeutics, Inc.
Price:  
9.50 
USD
Volume:  
21,258,052.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PSTX Relative Valuation

-188.9%
Upside

As of 2025-07-10, the Relative Valuation of Poseida Therapeutics, Inc. (PSTX) is (8.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.50 USD, the upside of Poseida Therapeutics, Inc. based on Relative Valuation is -188.9%.

The range of the Relative Valuation is (6.43) - (11.68) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 8.8x - 18.7x 13.3x
Forward P/E multiples 10.3x - 21.3x 13.8x
Fair Price (6.43) - (11.68) (8.45)
Upside -167.7% - -223.0% -188.9%
9.50 USD
Stock Price
(8.45) USD
Fair Price

PSTX Relative Valuation - Historical P/E Data

Date P/E